Marrero J.A. Kulik L.M. Sirlin C.B. et al.

Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases.

Hepatology. 68: 723-750

Multiple interactive factors in hepatocarcinogenesis.

Cancer Lett. 346: 17-23

Hepatocellular carcinoma pathogenesis: from genes to environment.

Nat Rev Cancer. 6: 674-687Chalasani N. Younossi Z. Lavine J.E. et al.

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Hepatology. 67: 328-357Marengo A. Rosso C. Bugianesi E.

Liver cancer: connections with obesity, fatty liver, and cirrhosis.

Annu Rev Med. 67: 103-117Choi J.Y. Lee J.M. Sirlin C.B.

CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. development, growth, and spread: key pathologic and imaging aspects.

Radiology. 272: 635-654Narsinh K.H. Cui J. Papadatos D. et al.

Hepatocarcinogenesis and LI-RADS.

Abdom Radiol (NY). 43: 158-168

Viral hepatocarcinogenesis.

Oncogene. 29: 2309-2324Galli A. Svegliati-Baroni G. Ceni E. et al.

Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism.

Hepatology. 41: 1074-1084Herath N.I. Leggett B.A. MacDonald G.A.

Review of genetic and epigenetic alterations in hepatocarcinogenesis.

J Gastroenterol Hepatol. 21: 15-21Kim H. Oh B.K. Roncalli M. et al.

Large liver cell change in hepatitis B virus-related liver cirrhosis.

Hepatology. 50: 752-762Marchio A. Terris B. Meddeb M. et al.

Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation.

Mol Pathol. 54: 270-274Plentz R.R. Park Y.N. Lechel A. et al.

Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.

Hepatology. 45: 968-976Watanabe S. Okita K. Harada T. et al.

Morphologic studies of the liver cell dysplasia.

Cancer. 51: 2197-2205Gong L. Li Y.H. Su Q. et al.

Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes.

Histopathology. 56: 589-599Arakawa M. Kage M. Sugihara S. et al.

Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases.

Gastroenterology. 91: 198-208

Terminology of nodular hepatocellular lesions.

Hepatology. 22: 983-993Park Y.N. Yang C.P. Fernandez G.J. et al.

Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver.

Am J Surg Pathol. 22: 656-662Park Y.N. Kojiro M. Di Tommaso L. et al.

Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.

Cancer. 109: 915-923International Consensus Group for Hepatocellular Neoplasia; The International Consensus Group for Hepatocellular N

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia.

Hepatology. 49: 658-664Hytiroglou P. Park Y.N. Krinsky G. et al.

Hepatic precancerous lesions and small hepatocellular carcinoma.

Gastroenterol Clin North Am. 36 (): 867-887Kim T.H. Kim S.Y. Tang A. et al.

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update.

Clin Mol Hepatol. 25: 245-263Hanna R.F. Aguirre D.A. Kased N. et al.

Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features.

Radiographics. 28: 747-769Hayashi M. Matsui O. Ueda K. et al.

Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.

AJR Am J Roentgenol. 172: 969-976Matsui O. Kadoya M. Kameyama T. et al.

Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.

Radiology. 178: 493-497Matsui O. Kobayashi S. Sanada J. et al.

Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis.

Abdom Imaging. 36: 264-272Asayama Y. Yoshimitsu K. Nishihara Y. et al.

Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation.

AJR Am J Roentgenol. 190: W28-W34Tang A. Bashir M.R. Corwin M.T. et al.

Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review.

Radiology. 286: 29-48

Performance of Gd-EOB-DTPA-enhanced MRI for the diagnosis of LI-RADS 4 category hepatocellular carcinoma nodules with different diameters.

Oncol Lett. 16: 2725-2731Abd Alkhalik Basha M. Abd El Aziz El Sammak D. El Sammak A.A.

Diagnostic efficacy of the liver imaging-reporting and data system (LI-RADS) with CT imaging in categorising small nodules (10-20 mm) detected in the cirrhotic liver at screening ultrasound.

Clin Radiol. 72: 901 e901-e911Hytiroglou P. Theise N.D. Schwartz M. et al.

Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature.

Hepatology. 21: 703-708Theise N.D. Jia J. Sun Y. et al.

Progression and regression of fibrosis in viral hepatitis in the treatment era: the Beijing classification.

Mod Pathol. 31: 1191-1200Chernyak V. Kobi M. Flusberg M. et al.

Effect of threshold growth as a major feature on LI-RADS categorization.

Abdom Radiol (NY). 42: 2089-2100Wu H. Han X. Wang Z. et al.

Prediction of the Ki-67 marker index in hepatocellular carcinoma based on CT radiomics features.

Phys Med Biol. 65: 235048Ishigami K. Yoshimitsu K. Nishihara Y. et al.

Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.

Radiology. 250: 435-443Santillan C. Fowler K. Kono Y. et al.

LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.

Abdom Radiol (NY). 43: 75-81Kim B. Lee J.H. Kim J.K. et al.

The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging: correlation with pathology and dynamic CT.

Medicine (Baltimore). 97: e11142Cerny M. Chernyak V. Olivie D. et al.

LI-RADS version 2018 ancillary features at MRI.

Radiographics. 38: 1973-2001Wald C. Russo M.W. Heimbach J.K. et al.

New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.

Radiology. 266: 376-382Huh J. Kim K.W. Kim J. et al.

Pathology-MRI correlation of hepatocarcinogenesis: recent update.

J Pathol Transl Med. 49: 218-229Li M. Xin Y. Fu S. et al.

Corona enhancement and mosaic architecture for prognosis and selection between of liver resection versus transcatheter arterial chemoembolization in single hepatocellular carcinomas >5 cm without extrahepatic metastases: an imaging-based retrospective study.

Medicine (Baltimore). 95: e2458Stevens W.R. Gulino S.P. Batts K.P. et al.

Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance.

J Comput Assist Tomogr. 20: 337-342Cerny M. Bergeron C. Billiard J.S. et al.

LI-RADS for MR imaging diagnosis of hepatocellular carcinoma: performance of major and ancillary features.

Radiology. 288: 118-128Fraum T.J. Tsai R. Rohe E. et al.

Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the liver imaging reporting and data system version 2014.

Radiology. 286: 158-172Horvat N. Nikolovski I. Long N. et al.

Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.

Abdom Radiol (NY). 43: 169-178Efremidis S.C. Hytiroglou P. Matsui O.

Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges.

Eur Radiol. 17: 2969-2982Choi J.Y. Lee J.M. Sirlin C.B.

CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Radiology. 273: 30-50Yu J.S. Chung J.J. Kim J.H. et al.

Hypervascular focus in the nonhypervascular nodule (“nodule-in-nodule”) on dynamic computed tomography: imaging evidence of aggressive progression in hepatocellular carcinoma.

J Comput Assist Tomogr. 33: 131-135Brunt E. Aishima S. Clavien P.A. et al.

cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.

Hepatology. 68: 113-126Gigante E. Ronot M. Bertin C. et al.

Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma.

Liver Int. 39: 2386-2396Martin J. Sentis M. Zidan A. et al.

Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging.

Radiology. 195: 125-130Balci N.C. Befeler A.S. Bieneman B.K. et al.

Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging.

Acad Radiol. 16: 963-968Kutami R. Nakashima Y. Nakashima O. et al.

Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans.

J Hepatol. 33: 282-289Asayama Y. Nishie A. Ishigami K. et al.

Fatty change in moderately and poorly differentiated hepatocellular carcinoma on MRI: a possible mechanism related to decreased arterial flow.

Clin Radiol. 71: 1277-1283Nakanuma Y. Hirata K. Terasaki S. et al.

Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver disease.

Histol Histopathol. 13: 1077-1087Kitao A. Zen Y. Matsui O. et al.

Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography–radiologic-pathologic correlation.

Radiology. 252: 605-614

Diffusion-weighted MRI in the body: applications and challenges in oncology.

AJR Am J Roentgenol. 188: 1622-1635

Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver. A marker of incipient neoplastic lesions.

Arch Pathol Lab Med. 113: 916-920